The molecular functions of RIT1 and its contribution to human disease.
暂无分享,去创建一个
[1] K. Boyer,et al. Complicated ventricular arrhythmia and hematologic myeloproliferative disorder in RIT1‐associated Noonan syndrome: Expanding the phenotype and review of the literature , 2020, Molecular genetics & genomic medicine.
[2] A. Khalil,et al. RIT1: A Novel Biomarker in Glioblastoma , 2020, bioRxiv.
[3] Hongyan Chen,et al. LZTR1 inactivation promotes MAPK/ ERK pathway activation in glioblastoma by stabilizing oncoprotein RIT1 , 2020 .
[4] Jinjun Li,et al. HIF-1α-induced RIT1 promotes liver cancer growth and metastasis and its deficiency increases sensitivity to sorafenib. , 2019, Cancer letters.
[5] Clint L. Miller,et al. iPSC-Derived Cardiomyocytes Reveal Aberrant ERK5 and MEK1/2 Signaling Concomitantly Promote Hypertrophic Cardiomyopathy in RAF1-Associated Noonan Syndrome. , 2019, Circulation.
[6] B. Gelb,et al. Hypertrophic Cardiomyopathy in Noonan Syndrome Treated by MEK-Inhibition. , 2019, Journal of the American College of Cardiology.
[7] P. Bork,et al. Interactive Tree Of Life (iTOL) v4: recent updates and new developments , 2019, Nucleic Acids Res..
[8] Y. Matsubara,et al. New Noonan syndrome model mice with RIT1 mutation exhibit cardiac hypertrophy and susceptibility to β-adrenergic stimulation-induced cardiac fibrosis , 2019, EBioMedicine.
[9] F. McCormick,et al. RIT1 oncoproteins escape LZTR1-mediated proteolysis , 2019, Science.
[10] S. Jamuar,et al. The spectrum of genetic variants and phenotypic features of Southeast Asian patients with Noonan syndrome , 2019, Molecular genetics & genomic medicine.
[11] Jian Wang,et al. Clinical and mutation profile of pediatric patients with RASopathy-associated hypertrophic cardiomyopathy: results from a Chinese cohort , 2019, Orphanet Journal of Rare Diseases.
[12] F. Wang,et al. RIT1 suppresses esophageal squamous cell carcinoma growth and metastasis and predicts good prognosis , 2018, Cell Death & Disease.
[13] L. Petrucelli,et al. Converging pathways in neurodegeneration, from genetics to mechanisms , 2018, Nature Neuroscience.
[14] G. Rosenberger,et al. RIT1 controls actin dynamics via complex formation with RAC1/CDC42 and PAK1 , 2018, PLoS genetics.
[15] Frank McCormick,et al. RAS Proteins and Their Regulators in Human Disease , 2017, Cell.
[16] S. Mir,et al. IGF-1 mediated Neurogenesis Involves a Novel RIT1/Akt/Sox2 Cascade , 2017, Scientific Reports.
[17] P. Croisille,et al. Expanding the cardiac spectrum of Noonan syndrome with RIT1 variant: Left main coronary artery atresia causing sudden death. , 2017, European journal of medical genetics.
[18] B. Neel,et al. Cellular interplay via cytokine hierarchy causes pathological cardiac hypertrophy in RAF1-mutant Noonan syndrome , 2017, Nature Communications.
[19] S. Mir,et al. RIT1 GTPase Regulates Sox2 Transcriptional Activity and Hippocampal Neurogenesis* , 2016, The Journal of Biological Chemistry.
[20] R. Martín-Fernández,et al. RIT1: un nuevo gen causal del síndrome de Noonan , 2016 .
[21] I. Arroyo-Carrera,et al. [RIT1: a novel gene associated with Noonan syndrome]. , 2016, Revista de neurología (Ed. impresa).
[22] M. Digilio,et al. Congenital heart defects in Noonan syndrome and RIT1 mutation , 2016, Genetics in Medicine.
[23] T. Rinne,et al. Two cases of RIT1 associated Noonan syndrome: Further delineation of the clinical phenotype and review of the literature , 2016, American journal of medical genetics. Part A.
[24] M. Ikura,et al. Biochemical Classification of Disease-associated Mutants of RAS-like Protein Expressed in Many Tissues (RIT1)* , 2016, The Journal of Biological Chemistry.
[25] D. Mitter,et al. Genotype and phenotype in patients with Noonan syndrome and a RIT1 mutation , 2016, Genetics in Medicine.
[26] A. Křepelová,et al. A novel heterozygous RIT1 mutation in a patient with Noonan syndrome, leukopenia, and transient myeloproliferation—a review of the literature , 2016, European Journal of Pediatrics.
[27] I. Mihalek,et al. Mutations in RIT1 cause Noonan syndrome – additional functional evidence and expanding the clinical phenotype , 2016, Clinical genetics.
[28] O. Migita,et al. Spectrum of mutations and genotype–phenotype analysis in Noonan syndrome patients with RIT1 mutations , 2016, Human Genetics.
[29] H. Cavé,et al. Mutations in RIT1 cause Noonan syndrome with possible juvenile myelomonocytic leukemia but are not involved in acute lymphoblastic leukemia , 2016, European Journal of Human Genetics.
[30] K. Hlinkova,et al. New Mutations Associated with Rasopathies in a Central European Population and Genotype–Phenotype Correlations , 2016, Annals of human genetics.
[31] Y. Teng,et al. Elevated expression of RIT1 correlates with poor prognosis in endometrial cancer. , 2015, International journal of clinical and experimental pathology.
[32] S. Mansour,et al. The lymphatic phenotype in Noonan and Cardiofaciocutaneous syndrome , 2015, European Journal of Human Genetics.
[33] Yong Zhou,et al. Ras nanoclusters: Versatile lipid-based signaling platforms. , 2015, Biochimica et biophysica acta.
[34] Weikang Cai,et al. mTORC2 Is Required for Rit-Mediated Oxidative Stress Resistance , 2014, PloS one.
[35] M. Passos-Bueno,et al. Further evidence of the importance of RIT1 in Noonan syndrome , 2014, American journal of medical genetics. Part A.
[36] Manuel Desco,et al. K-RasV14I recapitulates Noonan syndrome in mice , 2014, Proceedings of the National Academy of Sciences.
[37] E. Obersztyn,et al. Contribution of RIT1 mutations to the pathogenesis of Noonan syndrome: Four new cases and further evidence of heterogeneity , 2014, American journal of medical genetics. Part A.
[38] John D McPherson,et al. Next-generation sequencing identifies rare variants associated with Noonan syndrome , 2014, Proceedings of the National Academy of Sciences.
[39] J. L. Costa,et al. Comprehensive massive parallel DNA sequencing strategy for the genetic diagnosis of the neuro-cardio-facio-cutaneous syndromes , 2014, European Journal of Human Genetics.
[40] J Wala,et al. Oncogenic RIT1 mutations in lung adenocarcinoma , 2014, Oncogene.
[41] G. Shi,et al. Rit subfamily small GTPases: regulators in neuronal differentiation and survival. , 2013, Cellular signalling.
[42] Toshihiko Ogura,et al. Gain-of-function mutations in RIT1 cause Noonan syndrome, a RAS/MAPK pathway syndrome. , 2013, American journal of human genetics.
[43] G. Stamp,et al. RAS and RHO Families of GTPases Directly Regulate Distinct Phosphoinositide 3-Kinase Isoforms , 2013, Cell.
[44] Ellen T. Gelfand,et al. The Genotype-Tissue Expression (GTEx) project , 2013, Nature Genetics.
[45] Solomon H. Snyder,et al. Erratum: Inositol polyphosphate multikinase is a coactivator of p53-mediated transcription and cell death (Science Signaling (2013) 6: 273 (er1) Doi: 10.1126/scisignal.6273er1) , 2013 .
[46] Benjamin E. Gross,et al. Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal , 2013, Science Signaling.
[47] J. Allanson,et al. Noonan syndrome , 2013, The Lancet.
[48] S. Miyano,et al. Novel recurrent mutations in the RAS-like GTP-binding gene RIT1 in myeloid malignancies , 2013, Leukemia.
[49] C. Moncman,et al. Rit GTPase Signaling Promotes Immature Hippocampal Neuronal Survival , 2012, The Journal of Neuroscience.
[50] Benjamin E. Gross,et al. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. , 2012, Cancer discovery.
[51] D. Higgins,et al. Fast, scalable generation of high-quality protein multiple sequence alignments using Clustal Omega , 2011, Molecular systems biology.
[52] Weikang Cai,et al. An evolutionarily conserved Rit GTPase–p38 MAPK signaling pathway mediates oxidative stress resistance , 2011, Molecular biology of the cell.
[53] P. Rosenberg,et al. Cancer in Noonan, Costello, cardiofaciocutaneous and LEOPARD syndromes , 2011, American journal of medical genetics. Part C, Seminars in medical genetics.
[54] G. Shi,et al. A Rit GTPase-p38 Mitogen-Activated Protein Kinase Survival Pathway Confers Resistance to Cellular Stress , 2011, Molecular and Cellular Biology.
[55] B. Neel,et al. MEK-ERK pathway modulation ameliorates disease phenotypes in a mouse model of Noonan syndrome associated with the Raf1(L613V) mutation. , 2011, The Journal of clinical investigation.
[56] A. Fernández-Medarde,et al. Ras in cancer and developmental diseases. , 2011, Genes & cancer.
[57] J. Allanson,et al. Noonan Syndrome: Clinical Features, Diagnosis, and Management Guidelines , 2010, Pediatrics.
[58] C. Der,et al. Ras history , 2010, Small GTPases.
[59] G. Shi,et al. Src-dependent TrkA Transactivation Is Required for Pituitary Adenylate Cyclase-activating Polypeptide 38-mediated Rit Activation and Neuronal Differentiation , 2010, Molecular biology of the cell.
[60] Gabriele Gillessen-Kaesbach,et al. Molecular and clinical analysis of RAF1 in Noonan syndrome and related disorders: dephosphorylation of serine 259 as the essential mechanism for mutant activation , 2010, Human mutation.
[61] C. H. Conrad,et al. Isoproterenol-induced myocardial injury and diastolic dysfunction in mice: structural and functional correlates. , 2009, Comparative medicine.
[62] G. Shi,et al. Rit signaling contributes to interferon‐γ‐induced dendritic retraction via p38 mitogen‐activated protein kinase activation , 2008, Journal of neurochemistry.
[63] A. Fields,et al. Rit mutants confirm role of MEK/ERK signaling in neuronal differentiation and reveal novel Par6 interaction. , 2007, Biochimica et biophysica acta.
[64] M. Merchant,et al. Hsp27 Regulates Akt Activation and Polymorphonuclear Leukocyte Apoptosis by Scaffolding MK2 to Akt Signal Complex* , 2007, Journal of Biological Chemistry.
[65] G. Shi,et al. The Novel GTPase Rit Differentially Regulates Axonal and Dendritic Growth , 2007, The Journal of Neuroscience.
[66] H. Niu,et al. MAPK-activated Protein Kinase-2 (MK2)-mediated Formation and Phosphorylation-regulated Dissociation of the Signal Complex Consisting of p38, MK2, Akt, and Hsp27* , 2006, Journal of Biological Chemistry.
[67] T. Meyer,et al. PI(3,4,5)P3 and PI(4,5)P2 Lipids Target Proteins with Polybasic Clusters to the Plasma Membrane , 2006, Science.
[68] G. Shi,et al. A Novel Cyclic AMP-Dependent Epac-Rit Signaling Pathway Contributes to PACAP38-Mediated Neuronal Differentiation , 2006, Molecular and Cellular Biology.
[69] T. Yoshimori,et al. Small GTPase Proteins Rin and Rit Bind to PAR6 GTP-dependently and Regulate Cell Transformation* , 2005, Journal of Biological Chemistry.
[70] C. Montell,et al. Activated RIC, a small GTPase, genetically interacts with the Ras pathway and calmodulin during Drosophila development , 2005, Developmental dynamics : an official publication of the American Association of Anatomists.
[71] G. Shi,et al. Rit Contributes to Nerve Growth Factor-Induced Neuronal Differentiation via Activation of B-Raf-Extracellular Signal-Regulated Kinase and p38 Mitogen-Activated Protein Kinase Cascades , 2005, Molecular and Cellular Biology.
[72] D. Gilliland,et al. Mouse model of Noonan syndrome reveals cell type– and gene dosage–dependent effects of Ptpn11 mutation , 2004, Nature Medicine.
[73] J. Klein,et al. Heat Shock Protein 27 Controls Apoptosis by Regulating Akt Activation* , 2003, Journal of Biological Chemistry.
[74] Wei Liu,et al. [Amplification of RIT1 in hepatocellular carcinoma and its clinical significance]. , 2003, Ai zheng = Aizheng = Chinese journal of cancer.
[75] D. Andres,et al. Rit promotes MEK-independent neurite branching in human neuroblastoma cells , 2003, Journal of Cell Science.
[76] D. Andres,et al. Induction of Neurite Extension and Survival in Pheochromocytoma Cells by the Rit GTPase* , 2002, The Journal of Biological Chemistry.
[77] J. Gutkind,et al. Potent transforming activity of the small GTP‐binding protein Rit in NIH 3T3 cells: evidence for a role of a p38γ‐dependent signaling pathway , 2002, FEBS letters.
[78] Theresa M. Grana,et al. Rit, a non-lipid-modified Ras-related protein, transforms NIH3T3 cells without activating the ERK, JNK, p38 MAPK or PI3K/Akt pathways , 2000, Oncogene.
[79] D. Andres,et al. Biochemical characterization of the Ras-related GTPases Rit and Rin. , 1999, Archives of biochemistry and biophysics.
[80] C. Montell,et al. RIC, a calmodulin‐binding Ras‐like GTPase. , 1996, The EMBO journal.
[81] D. Zack,et al. Rin, a Neuron-Specific and Calmodulin-Binding Small G-Protein, and Rit Define a Novel Subfamily of Ras Proteins , 1996, The Journal of Neuroscience.
[82] G. Rubin,et al. Signalling by the sevenless protein tyrosine kinase is mimicked by Rasl activation , 1992, Nature.
[83] Frank McCormick,et al. The GTPase superfamily: conserved structure and molecular mechanism , 1991, Nature.
[84] W. Kabsch,et al. Structure of the guanine-nucleotide-binding domain of the Ha-ras oncogene product p21 in the triphosphate conformation , 1989, Nature.
[85] A. Roberts,et al. iPSC-Derived Cardiomyocytes Reveal Aberrant ERK5 and MEK1/2 Signaling Concomitantly Promote Hypertrophic Cardiomyopathy in RAF1-Associated Noonan Syndrome. , 2019, Circulation.
[86] Jacqueline Cherfils,et al. Regulation of small GTPases by GEFs, GAPs, and GDIs. , 2013, Physiological reviews.
[87] S. Shvartsman,et al. RASopathies: unraveling mechanisms with animal models , 2015, Disease Models & Mechanisms.
[88] W. Williams,et al. Survival implications: hypertrophic cardiomyopathy in Noonan syndrome. , 2011, Congenital heart disease.
[89] D. Kültz,et al. Molecular and evolutionary basis of the cellular stress response. , 2005, Annual review of physiology.
[90] Jiahuai Han,et al. Activation and signaling of the p38 MAP kinase pathway , 2005, Cell Research.
[91] P. Hawkins,et al. Crystal structure and functional analysis of Ras binding to its effector phosphoinositide 3-kinase gamma. , 2000, Cell.
[92] G M Rubin,et al. Ectopic expression of activated Ras1 induces hyperplastic growth and increased cell death in Drosophila imaginal tissues. , 1998, Development.
[93] G D'Hont,et al. [The Noonan syndrome]. , 1982, Acta oto-rhino-laryngologica Belgica.